Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma (vol 34, pg 3166, 2016)

Gounder M. M.

首页> 外文期刊>Journal of Clinical Oncology >Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma (vol 34, pg 3166, 2016)

【24h】

Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma (vol 34, pg 3166, 2016)

机译：Selinexor，核导出一流抑制剂的硒蛋白抑制剂（Vol 34，PG 3166,2016）的核核抑制剂综合征抑制剂研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Clinical Oncology》 |2017年第7期|共1页
作者
Gounder M. M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma (vol 34, pg 3166, 2016) [J] . Gounder M. M. Journal of Clinical Oncology . 2017,第7期

机译：Selinexor，核导出一流抑制剂的硒蛋白抑制剂（Vol 34，PG 3166,2016）的核核抑制剂综合征抑制剂研究
2. Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043). [J] . Sleijfer S, Ray Coquard I, Papai Z Journal of Clinical Oncology . 2009,第19期

机译：Pazopanib是一种多激酶血管生成抑制剂，用于患有复发性或难治性晚期软组织肉瘤的患者：来自欧洲组织的研究和治疗癌症软组织和骨肉瘤组的II期研究（EORTC研究62043）。
3. First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors [J] . Razak Albiruni R. Abdul, Mau-Soerensen Morten, Gabrail Nashat Y., Journal of Clinical Oncology . 2016,第34期

机译：Selinexor（一种核出口的选择性抑制剂）在晚期实体瘤患者中的一流，首次人类I期研究
4. X-ray phase-contrast imaging study of soft tissue and bone samples [C] . Dachao Gao, Andrew Pogany, Andrew W. Stevenson, Conference on physics of medical imaging . 1999

机译：软组织和骨样的X射线相位对比度成像研究
5. Phase IB Study of Selinexor a First-in-Class Inhibitor of Nuclear Export in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma [O] . Mrinal M. Gounder, Alona Zer, William D. Tap, -1

机译：Selinexor（一种先进的核输出抑制剂）在晚期难治性骨或软组织肉瘤患者中的IB期研究
6. Phase II study of the mammalian target of rapamycin inhibitor ridaforolimus in patients with advanced bone and soft tissue sarcomas. [O] . Chawla Sant P, Staddon Arthur P, Baker Laurence H, 2012

机译：雷帕霉素抑制剂ridaforolimus在晚期骨和软组织肉瘤患者中的哺乳动物靶点II期研究。

Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma (vol 34, pg 3166, 2016)

著录项

相似文献

相关主题

期刊订阅